Lucid Diagnostics Inc. (LUCD) Revenue History
Annual and quarterly revenue from 2018 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LUCD Revenue Growth
LUCD Revenue Analysis (2018–2024)
As of May 8, 2026, Lucid Diagnostics Inc. (LUCD) generated trailing twelve-month (TTM) revenue of $3.2 million, reflecting significant decline in growth of -100.0% year-over-year. The most recent quarter (Q3 2025) recorded $0 in revenue, down 100.0% sequentially.
Looking at the longer-term picture, LUCD's historical revenue data shows a 3-year CAGR of +105.6%. The company achieved its highest annual revenue of $4.3 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including GKOS (+36.3% YoY), NVCR (+8.5% YoY), and NNOX (+15.2% YoY), LUCD has underperformed the peer group in terms of revenue growth. Compare LUCD vs GKOS →
LUCD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LUCDCurrent | $3M | -100.0% | - | -1059.6% | |
 GKOS | $507M | +36.3% | +17.7% | -17.1% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 NNOX | $11M | +15.2% | - | -502.9% | |
 CDXS | $70M | +18.6% | +0.4% | -54.5% | |
 EXAS | $3.2B | +17.7% | +16.8% | -6.4% |
LUCD Historical Revenue Data (2018–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $4.3M | +79.0% | $-3,920,000 | -90.2% | $-46,052,000 | -1059.6% |
| 2023 | $2.4M | +544.0% | $-6,050,000 | -249.2% | $-48,482,000 | -1996.8% |
| 2022 | $377K | -24.6% | $-3,237,000 | -858.6% | $-56,171,000 | -14899.5% |
| 2021 | $500K | - | $-85,000 | -17.0% | $-27,419,000 | -5483.8% |
| 2020 | $0 | - | $0 | - | $-8,280,000 | - |
| 2019 | $0 | - | $0 | - | $-4,421,000 | - |
| 2018 | $0 | - | $0 | - | $-1,126,000 | - |
See LUCD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LUCD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LUCD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLUCD — Frequently Asked Questions
Quick answers to the most common questions about buying LUCD stock.
Is LUCD's revenue growth accelerating or slowing?
LUCD revenue declined -100.0% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $3M. This reverses the prior growth trend.
What is LUCD's long-term revenue growth rate?
Lucid Diagnostics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -100.0% is below this long-term average.
How is LUCD's revenue distributed by segment?
LUCD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2024 are available for download. Segment mix reveals concentration and diversification trends.